Wapnick Pamela's most recent trade in Metagenomi Inc. was a trade of 1,808 Common Stock done at an average price of $1.9 . Disclosure was reported to the exchange on March 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Metagenomi Inc. | Pamela Wapnick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.88 per share. | 05 Mar 2025 | 1,808 | 59,684 | - | 1.9 | 3,390 | Common Stock |
Metagenomi Inc. | Wapnick Pamela | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.86 per share. | 05 Dec 2024 | 1,559 | 61,492 | - | 1.9 | 2,900 | Common Stock |
Metagenomi Inc. | Wapnick Pamela | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.88 per share. | 05 Sep 2024 | 6,265 | 63,051 | - | 2.9 | 18,043 | Common Stock |
Metagenomi Inc. | Pamela Wapnick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 291,450 | 291,450 | - | - | Stock Option (Right to Buy) | |
Metagenomi Inc. | Pamela Wapnick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 69,316 | 69,316 | - | 0 | Common Stock |